What are Somatostatin Analog drugs?

Somatostatin Analog drugs are pharmacologic agents that share a common mechanism (typically targeting Somatostatin receptor type 2). 9 are currently marketed, with 9 more in clinical development.

What are the marketed Somatostatin Analog drugs?

Marketed Somatostatin Analog drugs include Somatuline Depot, Sandostatin, Sandostatin ® injection, Inj. Octreotide, Octreotide LAR, Octreotide Injection.

Somatostatin Analog

9 marketed 9 in Phase 3

This page covers all Somatostatin Analog drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Somatostatin receptor type 2, Somatostatin receptors (SSTR2, SSTR5), Somatostatin receptors (SSTR).

Targets

Somatostatin receptor type 2 · Somatostatin receptors (SSTR2, SSTR5) · Somatostatin receptors (SSTR) · somatostatin receptor

Marketed (9)

Somatuline Depot · Ipsen Pharma · Other · 1200
Somatuline Depot works by mimicking the natural hormone somatostatin to block the production of excess growth hormone.
Sandostatin · Novartis · Oncology · 305
Sandostatin works by mimicking the natural hormone somatostatin to inhibit the release of various hormones and growth factors.
Sandostatin ® injection · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Oncology; Endocrinology
Sandostatin (octreotide) is a somatostatin analog that binds to somatostatin receptors on neuroendocrine cells to inhibit the secretion of growth hormone, insulin, and other hormones.
Inj. Octreotide · PVS Memorial Hospital · Oncology
Octreotide is a somatostatin analog that binds to somatostatin receptors on neuroendocrine cells and blood vessels, inhibiting the release of various hormones and reducing blood flow to tumors.
Octreotide LAR · Cedars-Sinai Medical Center · Endocrinology, Oncology
Octreotide LAR is a long-acting somatostatin analog that binds to somatostatin receptors to inhibit the secretion of growth hormone, insulin, and other hormones.
Octreotide Injection · Centre Hospitalier Universitaire, Amiens · Oncology; Endocrinology
Octreotide is a somatostatin analog that binds to somatostatin receptors to inhibit the secretion of various hormones and reduce blood flow to tumors.
Octreotide (drug) · Lahore General Hospital · Oncology; Endocrinology
Octreotide is a somatostatin analog that binds to somatostatin receptors on neuroendocrine cells and blood vessels to inhibit the secretion of various hormones and reduce blood flow to tumors.
LAR Lanreotide · Memorial Sloan Kettering Cancer Center · Oncology
Lanreotide is a somatostatin analog that binds to somatostatin receptors to inhibit the secretion of growth hormone and other hormones.
Sandostatin LAR · Pfizer · Endocrinology / Oncology
Sandostatin LAR is a long-acting somatostatin analog that binds to somatostatin receptors to inhibit the secretion of growth hormone and other hormones.

Phase 3 pipeline (9)

Lanreotide ATG · Camurus AB · Oncology / Endocrinology
Lanreotide is a somatostatin analog that binds to somatostatin receptors to inhibit the secretion of growth hormone and other hormones.
Sanvar® (vapreotide) · Debiovision · Oncology
Vapreotide is a somatostatin analog that binds to somatostatin receptors to inhibit the secretion of various hormones and reduce symptoms in neuroendocrine tumors.
long-acting Octreotide. · Jiangsu HengRui Medicine Co., Ltd. · Oncology; Endocrinology
Long-acting octreotide is a somatostatin analog that binds to somatostatin receptors to inhibit the secretion of various hormones and growth factors.
Octreotide Microspheres · Shanghai Zhongshan Hospital · Oncology
Octreotide microspheres are a long-acting formulation of the somatostatin analog octreotide that binds somatostatin receptors to inhibit hormone secretion and tumor growth.
Lanreotide microparticles · Ipsen · Oncology, Endocrinology
Lanreotide is a somatostatin analog that binds to somatostatin receptors to inhibit the secretion of growth hormone and other hormones.
Somatostatin (octreotide) · University Hospital Freiburg · Oncology; Endocrinology
Octreotide is a somatostatin analog that binds to somatostatin receptors on neuroendocrine cells and blood vessels to inhibit the secretion of various hormones and reduce blood flow to tumors.
Long-acting somatostatin · Mario Negri Institute for Pharmacological Research · Endocrinology / Oncology
Long-acting somatostatin is a somatostatin analog that binds to somatostatin receptors to inhibit the secretion of various hormones and growth factors.
Lanreotide LP 90 · University Hospital, Limoges · Oncology; Endocrinology
Lanreotide is a somatostatin analog that binds to somatostatin receptors to inhibit the secretion of growth hormone and other hormones.
octreotide capsules · Chiasma, Inc. · Endocrinology
Octreotide capsules mimic the natural hormone somatostatin to decrease production of growth hormone and other hormones.